The York-based animal health business, Animalcare Group, has sold its majority shareholding in Identicare to BG Bidco 21 Limited, owned by funds managed by Bridgepoint Advisors II Limited, for £24.9m in cash. This transaction marks a significant value realization for the company and its shareholders, allowing Animalcare Group to focus on growth in the pharmaceutical-based animal health market. Following the separation of Identicare from the UK pharmaceuticals business within Animalcare Ltd earlier this year, the balance sheet of the Group has been strengthened, enabling the acceleration of organic and inorganic growth initiatives. Jenny Winter, Chief Executive Officer, expressed pride in the achievements with Identicare and emphasized the importance of the sale in strengthening the financial position of the Group, providing additional flexibility and resources for the growth of the pharmaceutical-focused animal health business.
Dear reader, we appreciate your readership on our news site. Journalism is a costly endeavor, and we heavily rely on advertising and revenue from both print and digital sources to sustain our editorially driven news site and magazine. The Covid-19 pandemic has had a profound impact on our industry, significantly affecting the advertising revenues that support our journalists and website costs. We kindly ask for your support – a small donation of just £1 or a subscription to our magazine for £31.50 per year can help us weather the challenges and continue providing quality journalism. By subscribing, you will gain unlimited access to our website and magazine, along with VIP event invitations, preferential rates to our awards, and exclusive content. To subscribe, please click here, and we extend our best wishes to you during this time.
